Clinical implications of the interaction between 2,3-diphosphoglycerate and haemoglobin.
D000138:Acidosis / Q000097:blood; D000740:Anemia / Q000097:blood; D000818:Animals; D001665:Binding Sites; D001793:Blood Preservation; D006348:Cardiac Surgical Procedures; D004163:Diphosphoglyceric Acids / Q000097:blood*; D004912:Erythrocytes / Q000378:metabolism; D005112:Extracorporeal Circulation; D006019:Glycolysis; D006453:Hemoglobinopathies / Q000097:blood; D006454:Hemoglobins; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D000860:Hypoxia / Q000097:blood; D010100:Oxygen / Q000097:blood; D010108:Oxyhemoglobins; D010313:Partial Pressure; D010710:Phosphates / Q000097:blood; D011817:Rabbits; D012769:Shock / Q000097:blood
D004163:Diphosphoglyceric Acids; D006454:Hemoglobins; D006728:Hormones; D010108:Oxyhemoglobins; D010710:Phosphates; D010100:Oxygen